BED BATH & BEYOND, INC.·4

Jan 27, 4:06 PM ET

Lee Adrianne 4

4 · BED BATH & BEYOND, INC. · Filed Jan 27, 2026

Research Summary

AI-generated summary of this filing

Updated

BBBY President & CFO Lee Adrianne Receives Shares; Withholds for Taxes

What Happened
Lee Adrianne, President and Chief Financial Officer of Bed Bath & Beyond, had restricted/derivative awards convert and/or vest on January 23, 2026. The filing reports 20,965 shares acquired via exercise/conversion of derivatives and a separate withholding of 6,049 shares to cover taxes (withheld at $6.87 per share for $41,557). An earlier grant of 6,043 derivative awards was reported from October 7, 2025.

Key Details

  • Transaction dates: primary activity on 2026-01-23 (vesting/conversion and tax withholding); a prior grant dated 2025-10-07.
  • Reported transactions and codes:
    • M (exercise/conversion of derivative): 20,965 shares acquired (reported $0.00 per share; aggregate shown as $2 in filing).
    • F (payment of exercise price / tax liability): 6,049 shares withheld/disposed at $6.87 each = $41,557 (share surrender for taxes).
    • A (grant/award): 6,043 derivative units granted on 2025-10-07 (reported as derivative/award).
  • Shares owned after the transactions: Not specified in the Form 4 filing.
  • Footnotes of note:
    • F1: Thes were restricted stock units (RSUs) that vest in three equal installments on Jan 23 of 2024, 2025 and 2026; vested RSUs are delivered promptly after vesting.
    • F2: Represents warrants issued 2025-10-07 as a pro‑rata distribution; each warrant allows purchase of one common share at $15.50. That distribution was exempt from immediate Section 16 reporting.
  • Timeliness: The Form 4 was filed on 2026-01-27 for transactions dated 2026-01-23 (filed four days later), which is later than the standard two-business-day Form 4 deadline.

Context

  • The primary activity appears to be vesting/conversion of awards (an acquisition of shares), with a routine share withholding to cover tax obligations. Withholdings (F code) are common and are not the same as an open‑market sale for cash.
  • The derivative/warrant details (including the $15.50 exercise price referenced in footnote F2) indicate the holder has or had derivative instruments; the reported $0.00 per share on some conversion lines likely reflects reporting conventions for vested RSUs or conversions rather than a market purchase.
  • These transactions are informational — vesting and tax withholdings are common compensation events and do not by themselves signal insider buying or selling intent.

Insider Transaction Report

Form 4
Period: 2026-01-23
Lee Adrianne
President & CFO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-23$0.00/sh+20,965$281,399 total
  • Tax Payment

    Common Stock

    2026-01-23$6.87/sh6,049$41,55775,350 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1]
    2026-01-2320,96575,336 total
    Common Stock (20,965 underlying)
  • Award

    Common Stock Warrant

    [F2]
    2025-10-07+6,0436,043 total
    Exercise: $15.50From: 2025-12-03Exp: 2026-10-07Common Stock (6,043 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units have vested in three equal installments at the close of business on January 23, 2024, January 23, 2025, and January 23, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules.
  • [F2]Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one common share at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.
Signature
/s/ Christina Wheeler, Attorney-in-Fact|2026-01-27

Documents

1 file
  • 4
    form4-01272026_090113.xmlPrimary